1. Home
  2. MYGN vs EB Comparison

MYGN vs EB Comparison

Compare MYGN & EB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.00

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo Eventbrite Inc.

EB

Eventbrite Inc.

HOLD

Current Price

$4.51

Market Cap

442.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
EB
Founded
1991
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
442.9M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
MYGN
EB
Price
$5.00
$4.51
Analyst Decision
Buy
Buy
Analyst Count
8
2
Target Price
$7.64
$5.00
AVG Volume (30 Days)
1.5M
1.8M
Earning Date
05-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.62
EPS
N/A
N/A
Revenue
$771,400,000.00
$326,134,000.00
Revenue This Year
$7.19
N/A
Revenue Next Year
$5.64
$4.70
P/E Ratio
N/A
N/A
Revenue Growth
2.33
24.99
52 Week Low
$3.76
$1.81
52 Week High
$10.32
$4.51

Technical Indicators

Market Signals
Indicator
MYGN
EB
Relative Strength Index (RSI) 49.81 77.04
Support Level $5.02 $4.43
Resistance Level $5.63 N/A
Average True Range (ATR) 0.40 0.02
MACD 0.09 0.00
Stochastic Oscillator 59.63 100.00

Price Performance

Historical Comparison
MYGN
EB

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About EB Eventbrite Inc.

Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.

Share on Social Networks: